Accel Diagnostics
AccelDx is a medical device company developing pScreen™, a disruptive blood testing platform for the diagnosis and management of medical conditions in the Home/Point-of-Care setting. AccelDx’s solution enables physicians/patients to manage diseases in a timely and effective manner, thereby reducing cost and hospitalizations. AccelDx is currently focusing on pScreen-BNP™ for the in home daily monitoring of heart condition to prevent heart failure (HF) related re-hospitalizations: an untapped market opportunity of $1.9B.